English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/222997
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals

AuthorsMartinez-Fleta, Pedro; Alfranca, Arántzazu; González-Álvaro, Isidoro; Casasnovas, José María ; Fernández-Soto, Daniel; Esteso, Gloria; Cáceres-Martell, Yaiza; Gardeta, Sofía; López-Sanz, Celia; Prat, Salomé; Mateu-Alberoa, Tamara; Gabrie, Ligia; López-Granados, Eduardo; Sánchez-Madrid, Francisco; Reyburn, H. T. ; Rodríguez-Frade, José Miguel; Valés-Gómez, Mar
Issue Date15-Nov-2020
PublisherAmerican Association of Immunologists
CitationJournal of Immunology 205(10): ji2000842 (2020)
AbstractCurrently, there is a need for reliable tests that allow identification of individuals that have been infected with SARS-CoV-2 even if the infection was asymptomatic. To date, the vast majority of the serological tests for SARS-CoV-2–specific Abs are based on serum detection of Abs to either the viral spike glycoprotein (the major target for neutralizing Abs) or the viral nucleocapsid protein that is known to be highly immunogenic in other coronaviruses. Conceivably, exposure of Ags released from infected cells could stimulate Ab responses that might correlate with tissue damage and, hence, they may have some value as a prognostic indicator. We addressed whether other nonstructural viral proteins, not incorporated into the infectious viral particle, specifically the viral cysteine-like protease, might also be potent immunogens. Using ELISA tests, coating several SARS-CoV-2 proteins produced in vitro, we describe that COVID-19 patients make high titer IgG, IgM, and IgA Ab responses to the Cys-like protease from SARS-CoV-2, also known as 3CLpro or Mpro, and it can be used to identify individuals with positive serology against the coronavirus. Higher Ab titers in these assays associated with more-severe disease, and no cross-reactive Abs against prior betacoronavirus were found. Remarkably, IgG Abs specific for Mpro and other SARS-CoV-2 Ags can also be detected in saliva. In conclusion, Mpro is a potent Ag in infected patients that can be used in serological tests, and its detection in saliva could be the basis for a rapid, noninvasive test for COVID-19 seropositivity.
Publisher version (URL)https://doi.org/10.4049/jimmunol.2000842
URIhttp://hdl.handle.net/10261/222997
DOI10.4049/jimmunol.2000842
ISSN0022-1767
E-ISSN1550-6606
Appears in Collections:(CNB) Artículos
(VICYT) Colección Especial COVID-19
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.